Data Dictionary: ZfkD Cancer Registry (Germany): Difference between revisions

From Beacon
No edit summary
No edit summary
Line 2: Line 2:
Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.
Go back to [[Database: ZfKD Cancer Registry (Germany)]] page.


Source: [https://www.krebsdaten.de/Krebs/DE/Content/Forschungsdaten/Informationen_datensatz/info_datensatz_node.html Click here to learn more].


{| class="wikitable"
{| class="wikitable"
! Split !! Explanation
! Variable (English) !! Description !! Value range
|-
|-
| variables || Elements in the XML scheme that do not branch further and thus contain values
| Date of birth || Patient's date of birth represented in international format YYYY-MM-DD.  || Date YYYY-MM-DD
|-
|-
| Belongs to || Overarching element in the XML scheme. For reasons of clarity, however, not all levels are shown in the tree
| Date of death or last known alive date || Date of death (imputed) or last known alive date. For DCO cases, date of death = incidence date. || Date YYYY-MM-DD
|-
|-
| OBDS module || Provides the reference to the oncological basic data set (OBDS) or the corresponding diagnosis -specific module
| Other cause of death, ICD-10 code || Other cause(s) of death as reported to the registry, ICD-10 code || ICD-10 code
|-
|-
| Cardinality || "Here in ""1 - is listed exactly once"" and ""n - can occur several times"" within the overriding element"
| Other cause of death, ICD-10 version || ICD-10 version used to encode other cause(s) of death || ICD-10 version
|-
|-
| Optional || "Variables with the ""N"" value are mandatory in the transmission. It is not taken into account here whether the variables each have a form like ""unknown"" or similar. exhibit"
| Diagnosis date || Date of incidence represented in international format YYYY-MM-DD. For DCO cases, incidence date = date of death. || Date YYYY-MM-DD
|-
|-
| Value range || A reference to the value area is mentioned if deviating from OBDS
| Year of incidence || Year of incidence. For DCO cases, year of incidence is equal to year of death. || Date YYYY
|-
|-
| agreement || Agreements on this context can be found on the website
| Age at diagnosis || Number of years between date of birth and date of diagnosis || Age (years)
|-
|-
| annotation || "The data record consists of the elements ""person"", ""tumor"" and ""primary diagnosis"", each of which is present in each individual data set, whereby several tumors can be assigned to one person. In contrast, the elements ""operation"", ""systemic therapy"", ""radiation therapy"" and ""consequential event"" are optionally available in the data set. These elements can also be used several times for the same disease case, which enables also to map complex therapy and illness courses. The actual variables containing the evaluable information (column B) are each assigned to one of these elements (column C)."
| Place of residence at diagnosis || "Place of residence at diagnosis, represented by 5-digit area code (""Kreiskennziffer"")" || 5-digit area code
|}
 
{| class="wikitable"
! No !! variable !! Surname !! Belongs to !! OBDS/module !! Cardinality !! Optional !! Value range !! agreement
|-
| 1 || Gender ||  || person || 3.9 || 1 || n ||  ||
|-
| 2 || birth date ||  || person || 3.10 || 1 || n || moon ||
|-
| 3 || Died (vital status) ||  || person || new || 1 || n || Died yes/no || #Vitalstatus
|-
| 4 || Date vital status ||  || person || new || 1 || n || moon ||
|-
| 5 || The cause of death (official basic disorders) n. ICD code ||  || person || 20.3 || 1 || J ||  || #TODESULE
|-
| 6 || The cause of death (official basic disorders) n. ICD edition ||  || person || 20.4 || 1 || J ||  ||
|-
| 7 || Further causes of death n. ICD code ||  || person || new || n || J ||  ||
|-
| 8th || Further causes of death n. ICD version ||  || person || new || n || J ||  ||
|-
| 9 || Diagnostic datum ||  || Primary diagnosis || 5.6 || 1 || n || moon ||
|-
| 10 || Place of residence (district) b. diagnosis ||  || Primary diagnosis || 3.15 || 1 || n || District index (5 digits) ||
|-
| 11 || Diagnosis according to ICD code ||  || Primary diagnosis || 5.1 || 1 || n || four -digit ||
|-
| 12 || Diagnosis according to ICD version ||  || Primary diagnosis || 5.2 || 1 || n ||  ||
|-
| 13 || Localization (ICD-O) code ||  || Primary diagnosis || 5.4 || 1 || n ||  ||
|-
| 14 || Localization (ICD-O) version ||  || Primary diagnosis || 5.5 || 1 || J ||  ||
|-
| 15 || Morphology (ICD-O) code ||  || Primary diagnosis || 6.3 || 1 || n ||  || #Morphology [InlineCard]
|-
| 16 || Morphology (ICD-O) version (or Blue Book) ||  || Primary diagnosis || 6.4 || 1 || J ||  ||
|-
| 17 || Grading ||  || Primary diagnosis || 6.6 || 1 || J ||  ||
|-
| 18 || Number of lymph nodes examined ||  || Primary diagnosis || 6.7 || 1 || J ||  ||
|-
| 19 || Number of affected lymph nodes ||  || Primary diagnosis || 6.8 || 1 || J ||  ||
|-
| 20 || CTNM version ||  || Primary diagnosis || 8.2 || 1 || J ||  || #Tnm- [inlineCard]
|-
| 21 || CTNM-Y symbol ||  || Primary diagnosis || 8.3 || 1 || J ||  ||
|-
| 22 || CTNM-R-icon ||  || Primary diagnosis || 8.4 || 1 || J ||  ||
|-
| 23 || CTNM-A symbol ||  || Primary diagnosis || 8.5 || 1 || J ||  ||
|-
| 24 || CTNM-T ||  || Primary diagnosis || 8.9 || 1 || J ||  ||
|-
| 25 || CTNM-N ||  || Primary diagnosis || 8.11 || 1 || J ||  ||
|-
| 26 || CTNM-M ||  || Primary diagnosis || 8.12 || 1 || J ||  ||
|-
| 27 || CTNM-prefix t ||  || Primary diagnosis || 8.6 || 1 || J ||  ||
|-
| 28 || CTNM-Prefix-N ||  || Primary diagnosis || 8.7 || 1 || J ||  ||
|-
| 29 || CTNM-Prefix-M ||  || Primary diagnosis || 8.8 || 1 || J ||  ||
|-
| 30 || CTNM: M symbol ||  || Primary diagnosis || 8.10 || 1 || J ||  ||
|-
| 31 || CTNM: L-category ||  || Primary diagnosis || 8.13 || 1 || J ||  ||
|-
| 32 || CTNM: V-category ||  || Primary diagnosis || 8.14 || 1 || J ||  ||
|-
| 33 || CTNM: PN category ||  || Primary diagnosis || 8.15 || 1 || J ||  ||
|-
| 34 || CTNM: S category ||  || Primary diagnosis || 8.16 || 1 || J ||  ||
|-
| 35 || C-TNM-Uicc ||  || Primary diagnosis || 8.17 || 1 || J ||  ||
|-
| 36 || PTNM version ||  || Primary diagnosis || 8.2 || 1 || J ||  ||
|-
| 37 || Ptnm-Y symbol ||  || Primary diagnosis || 8.3 || 1 || J ||  ||
|-
| 38 || PTNM-R-icon ||  || Primary diagnosis || 8.4 || 1 || J ||  ||
|-
| 39 || PTNM-A symbol ||  || Primary diagnosis || 8.5 || 1 || J ||  ||
|-
| 40 || PTNM-T ||  || Primary diagnosis || 8.9 || 1 || J ||  ||
|-
| 41 || Ptnm-n ||  || Primary diagnosis || 8.11 || 1 || J ||  ||
|-
| 42 || PTNM-M ||  || Primary diagnosis || 8.12 || 1 || J ||  ||
|-
| 43 || PTNM-Prefix-T ||  || Primary diagnosis || 8.6 || 1 || J ||  ||
|-
| 44 || Ptnm-Prefix-N ||  || Primary diagnosis || 8.7 || 1 || J ||  ||
|-
| 45 || PTNM-Prefix-M ||  || Primary diagnosis || 8.8 || 1 || J ||  ||
|-
| 46 || PTNM: M symbol ||  || Primary diagnosis || 8.10 || 1 || J ||  ||
|-
| 47 || PTNM: L-category ||  || Primary diagnosis || 8.13 || 1 || J ||  ||
|-
| 48 || PTNM: V-category ||  || Primary diagnosis || 8.14 || 1 || J ||  ||
|-
| 49 || PTNM: PN category ||  || Primary diagnosis || 8.15 || 1 || J ||  ||
|-
| 50 || PTNM: S category ||  || Primary diagnosis || 8.16 || 1 || J ||  ||
|-
| 51 || ptnm-uicc ||  || Primary diagnosis || 8.17 || 1 || J ||  || #Uicc- [inlineCard]
|-
| 52 || Mestastases seat ||  || Primary diagnosis || 11.1 || n || J ||  || #Seat-the remote metastasis- (Age-primary diagnostic diagnosis [inlinecard])
|-
| 53 || Further classification: name ||  || Primary diagnosis || 9.2 || n || J ||  ||
|-
| 54 || Further classification: stage (expression) ||  || Primary diagnosis || 9.3 || n || J ||  ||
|-
| 55 || Diagnostic protection ||  || Primary diagnosis || 5.7 || 1 || n || Like OBDS, additionally DCO and unknown || #Diagnosis protection
|-
| 56 || Side locals in paired organs ||  || Primary diagnosis || 5.8 || 1 || J ||  ||
|-
| 57 || Dcn ||  || Primary diagnosis || new || 1 || n || Yes No || #DCN- (Death Certificate Notified)
|-
| 58 || Survival time (distance diagnostic death) ||  || Primary diagnosis || new ||  || J || Number of days ||
|-
| 59 || Tumor size in mm (invasive) ||  || Primary diagnosis || Chest module || 1 || J ||  ||
|-
| 60 || Tumor size in mm (DCIS) ||  || Primary diagnosis || Chest module || 1 || J ||  ||
|-
| 61 || Prate therapeutic menopause status ||  || Primary diagnosis || Chest module || 1 || J ||  ||
|-
| 62 || Hormone receptor status :: estrogen ||  || Primary diagnosis || Chest module || 1 || J ||  ||
|-
| 63 || Hormone receptor status: progesterone ||  || Primary diagnosis || Chest module || 1 || J ||  ||
|-
| 64 || Her2neu status ||  || Primary diagnosis || Chest module || 1 || J ||  ||
|-
| 65 || PSA value ||  || Primary diagnosis || Prostate module || 1 || J ||  ||
|-
| 66 || Date PSA ||  || Primary diagnosis || Prostate module || 1 || J ||  ||
|-
| 67 || Gleason score primary value ||  || Primary diagnosis || Prostate module || 1 || J ||  ||
|-
| 68 || Gleason score of secondary value ||  || Primary diagnosis || Prostate module || 1 || J ||  ||
|-
| 69 || Gleason score overall score ||  || Primary diagnosis || Prostate module || 1 || J ||  ||
|-
| 70 || Gleason score occasion ||  || Primary diagnosis || Prostate module || 1 || J ||  ||
|-
| 71 || Tumor thickness in mm ||  || Primary diagnosis || Melanoma module || 1 || J ||  ||
|-
| 72 || Ulceration ||  || Primary diagnosis || Melanoma module || 1 || J ||  ||
|-
| 73 || LDH ||  || Primary diagnosis || Melanoma module || 1 || J ||  ||
|-
|-
| 74 || Rectum: distance of the tumor underride to the anocutan line ||  || Primary diagnosis || Module Darm || 1 || J ||  ||
| Place of residence at diagnosis || "Place of residence at diagnosis, represented by 2-digit area code (""Bundesland"")" || 2-digit area code
|-
|-
| 75 || Mutation K-ras-Onkogen ||  || Primary diagnosis || Module Darm || 1 || J ||  ||  
| Tumor diagnosis, ICD-10 code || ICD-10 diagnostic code of tumor || ICD-10, 4-digit code
|-
|-
| 76 || Operating date ||  || surgery || 13.2 || 1 || n ||  ||  
| Tumor diagnosis, ICD-10 version || ICD-10 version used to encode tumor diagnosis || ICD-10 version
|-
|-
| 77 || Type of operation according to OPS code || || surgery || 13.3 || n || n || Ops ||
| Topography of tumor, ICD-O-3 code || Tumor site represented by ICD-O-3 topography code || ICD-O-3 (topography section) 4-digit code
|-
|-
| 78 || Type of operation according to OPS version ||  || surgery || 13.4 || 1 || n ||  ||
| Morphology of tumor, ICD-O-3 code || Morphology and behavior of tumor represented by 5-digit ICD-O-3 code. The fifth digit indicates tumor behavior (/0 benign; /1 uncertain; /2 carcinoma in situ; /3 malignant). || ICD-O-3 (morphology section), 5-digit code
|-
|-
| 79 || Intention of the operation ||  || surgery || 13.1 || 1 || n ||  ||
| Number of lymph nodes examined || Number of lymph nodes that were examined for the presence of cancer cells || (n) = number of lymph nodes
|-
|-
| 80 || Local assessment residual status || || surgery || 10.1 || 1 || J ||  || #Total assessment residual status (for-surgery [inlineCard])-not-transmitted
| Number of lymph nodes affected || Number of lymph nodes that contain cancer cells || (n) = number of lymph nodes
|-
|-
| 81 || Distance primary diagnosis to surgery ||  || surgery || recalculated) || 1 || J || Number of days ||  
| cTNM: T || Describes the size of the primary tumor. Staging according to tumor-specific TNM. || T stage, tumor-specific
|-
|-
| 82 || Start radiation therapy ||  || radiotherapy || 14.5 || 1 || n ||  ||  
| cTNM: N || Describes the degree of spread to regional lymph nodes. Staging according to tumor-specific TNM. || N stage, tumor-specific
|-
|-
| 83 || intention ||  || radiotherapy || 14.1 || 1 || J ||  ||  
| cTNM: UICC Stage || UICC Stage according to TNM. Describes the anatomical extent of disease. || UICC stage, tumor-specific
|-
|-
| 84 || Position for the operation ||  || radiotherapy || 14.2 || 1 || J ||  ||  
| pTNM: T || Describes the size of the primary tumor. Staging according to tumor-specific TNM. || T stage, tumor-specific
|-
|-
| 85 || Application type ||  || radiotherapy || 14.7 || 1 || J ||  || #Applications-unspoken-
| pTNM: N || Describes the degree of spread to regional lymph nodes. Staging according to tumor-specific TNM. || N stage, tumor-specific
|-
|-
| 86 || Target area ||  || radiotherapy || 14.3 || 1 || ? ||  ||  
| pTNM: UICC stage || UICC Stage according to TNM. Describes the anatomical extent of disease. || UICC stage, tumor-specific
|-
|-
| 87 || Page target area || || radiotherapy || 14.4 || 1 || ? ||  ||
| Other classification system: name || Name and/or type of other classification(s) used || e.g. Ann Arbor staging, WHO Classification of CNS Tumors, AJCC
|-
|-
| 88 || Duration of radiation therapy || || radiotherapy || new (calculated from 14.5 and 14.6) || 1 || J ||  || #Permanent ray therapy
| Other classification system: stage || Stage assigned based on other classification system || Stage
|-
|-
| 89 || Distance primary diagnosis until the beginning of radiation therapy ||  || radiotherapy || recalculated) || 1 || J ||  ||
| Survival time || Time interval between incidence date and death || (n) = number of days
|-
|-
| 90 || Intention of systemic therapy ||  || Systemic therapy || 16.1 || 1 || n ||  ||
| Tumor size || Maximum diameter of invasive carcinoma (in mm) || (n) = tumor size in mm
|-
|-
| 91 || Position systemic therapy for the operation ||  || Systemic therapy || 16.2 || 1 || n ||  ||
| DCIS size || Maximum diameter of ductal carcinoma in situ (in mm) || (n) = DCIS size in mm
|-
|-
| 92 || Art d. Systemic therapy ||  || Systemic therapy || 16.3 || 1 || n ||  || #Art-Systemische-Therapy- (Oder-Awartenden) therapy
| PSA level || PSA level (ng/mL) || (n) = level in ng/mL
|-
|-
| 93 || substance || || Systemic therapy || 16.6 || n || J || Description or ATC code || #Building substance [InlineCard]
| PSA level date || Date of PSA blood test || Date YYYY-MM-DD
|-
|-
| 94 || protocol || || Systemic therapy || 16.4 || 1 || J ||  || #Settup protocol [inlineCard]
| Gleason: primary grade || Primary Gleason grade || 1, 2, 3, 4 or 5
|-
|-
| 95 || Start systemic therapy || || Systemic therapy || 16.5 || 1 || n ||  ||
| Gleason: secondary grade || Secondary Gleason grade || 1, 2, 3, 4 or 5
|-
|-
| 96 || Duration of systemic therapy ||  || Systemic therapy || recalculated) || 1 || J ||  ||  
| Gleason score || Gleason score || 2, 3, 4, 5, 6, 7, 7a, 7b, 8, 9 or 10
|-
|-
| 97 || Distance primary diagnosis until the beginning of systemic therapy ||  || Systemic therapy || recalculated) || 1 || J ||  ||
| Tumor thickness || Thickness of tumor (mm) || (n) = thickness in mm
|-
|-
| 98 || Date of follow -up event ||  || Consequence event || 17.1 || 1 || n ||  ||
| LDH level || LDH level (units per liter) || (n) = level in U/L
|-
|-
| 99 || TNM version ||  || Consequence event || 8.2 || 1 || J ||  ||  
| Surgery date || Surgery date represented in ISO 8601 format YYYY-MM-DD. Year and month of surgery are collected from registries, day of surgery is assigned an arbitrary value. || Date YYYY-MM-DD
|-
|-
| 100 || TNM-Y symbol ||  || Consequence event || 8.3 || 1 || J ||  ||  
| Surgery type || OPS code of surgery || OPS code
|-
|-
| 101 || TNM-R-icon ||  || Consequence event || 8.4 || 1 || J ||  ||  
| OPS version || OPS version used to encode surgery type || OPS version number
|-
|-
| 102 || TNM-A symbol ||  || Consequence event || 8.5 || 1 || J ||  ||  
| Time to surgery || Number of days between diagnosis and surgery || (n) = number of days
|-
|-
| 103 || TNM-T ||  || Consequence event || 8.9 || 1 || J ||  ||  
| Radiotherapy start date || Radiotherapy start date || Date YYYY-MM-DD
|-
|-
| 104 || TNM-N ||  || Consequence event || 8.11 || 1 || J ||  ||  
| Percutaneous radiotherapy - Stereotactic || Indicates if percutaneous radiotherapy (external beam radiotherapy) was applied using stereotactic techniques. || ST = stereotactic
|-
|-
| 105 || TNM-M ||  || Consequence event || 8.12 || 1 || J ||  ||  
| Percutaneous radiotherapy - Respiratory-gated || Indicates if percutaneous radiotherapy (external beam radiotherapy) was respiratory-gated. || 4D = respiratory-gated
|-
|-
| 106 || TNM-prefix t ||  || Consequence event || 8.6 || 1 || J ||  ||  
| Radiotherapy duration || Number of days between diagnosis and surgery || (n) = number of days
|-
|-
| 107 || TNM Prefix-N ||  || Consequence event || 8.7 || 1 || J ||  ||  
| Time to radiotherapy || Time interval between incidence date and radiotherapy start date (days) || (n) = number of days
|-
|-
| 108 || TNM-Prefix-M ||  || Consequence event || 8.8 || 1 || J ||  ||  
| Systemic therapy drug || Medication(s) used for systemic therapy. Multiple medications require separate entries. || Name or: ATC code + ATC version
|-
|-
| 109 || TNM: M symbol ||  || Consequence event || 8.10 || 1 || J ||  ||  
| Systemic therapy protocol type || Systemic therapy protocol name or code. || "Name or: protocol code
|-
|-
| 110 || TNM: L-category ||  || Consequence event || 8.13 || 1 || J ||  ||
| Systemic therapy protocol || Systemic therapy protocol code. || Suggested guidance: https://plattform65c.atlassian.net/wiki/spaces/UMK/pages/15532519/Protokolle
|-
|-
| 111 || TNM: V-category ||  || Consequence event || 8.14 || 1 || J ||  ||  
| Systemic therapy protocol || Systemic therapy protocol name || (name) = protocol name
|-
|-
| 112 || TNM: PN category ||  || Consequence event || 8.15 || 1 || J ||  ||  
| Systemic therapy protocol || Systemic therapy protocol version || (version) = protocol version
|-
|-
| 113 || TNM: S category ||  || Consequence event || 8.16 || 1 || J ||  ||  
| Systemic therapy start date || Systemic therapy start date || Date YYYY-MM-DD
|-
|-
| 114 || TNM-Uicc ||  || Consequence event || 8.17 || 1 || J ||  ||  
| Systemic therapy duration || Systemic therapy duration (days) || (n) = number of days
|-
|-
| 115 || Further classification: name ||  || Consequence event || 9.2 || 1 || J ||  ||  
| Time to systemic therapy || Time interval between incidence date and systemic therapy start date (days) || (n) = number of days
|-
|-
| 116 || Further classification: stage (expression) ||  || Consequence event || 9.3 || 1 || J ||  ||  
| Follow-up date || Date of most recent follow-up evaluation of tumor status || Date YYYY-MM-DD
|-
|-
| 117 || Total settlement tumor status ||  || Consequence event || 17.2 || 1 || n ||  ||  
| TNM: T || Describes the size of the primary tumor. Staging according to tumor-specific TNM. || T stage, tumor-specific
|-
|-
| 118 || Course of local tumor status ||  || Consequence event || 17.3 || 1 || J ||  ||  
| TNM: N || Describes the degree of spread to regional lymph nodes. Staging according to tumor-specific TNM. || N stage, tumor-specific
|-
|-
| 119 || Course tumor status lymph nodes ||  || Consequence event || 17.4 || 1 || J ||  ||  
| TNM: UICC stage || UICC Stage at follow-up according to TNM. Describes the anatomical extent of disease. || UICC stage, tumor-specific
|-
|-
| 120 || Course tumor status distant metastases || || Consequence event || 17.5 || 1 || J ||  ||
| Other classification system: name || Name and/or type of other classification(s) used || e.g. Ann Arbor staging, WHO Classification of CNS Tumors, AJCC
|-
|-
| 121 || Mestastases seat || || Consequence event || 11.1 || n || J
| Other classification system: stage || Stage assigned based on other classification system || Stage
|}
|}

Revision as of 17:01, 6 June 2024

Go back to Database: ZfKD Cancer Registry (Germany) page.


Variable (English) Description Value range
Date of birth Patient's date of birth represented in international format YYYY-MM-DD. Date YYYY-MM-DD
Date of death or last known alive date Date of death (imputed) or last known alive date. For DCO cases, date of death = incidence date. Date YYYY-MM-DD
Other cause of death, ICD-10 code Other cause(s) of death as reported to the registry, ICD-10 code ICD-10 code
Other cause of death, ICD-10 version ICD-10 version used to encode other cause(s) of death ICD-10 version
Diagnosis date Date of incidence represented in international format YYYY-MM-DD. For DCO cases, incidence date = date of death. Date YYYY-MM-DD
Year of incidence Year of incidence. For DCO cases, year of incidence is equal to year of death. Date YYYY
Age at diagnosis Number of years between date of birth and date of diagnosis Age (years)
Place of residence at diagnosis "Place of residence at diagnosis, represented by 5-digit area code (""Kreiskennziffer"")" 5-digit area code
Place of residence at diagnosis "Place of residence at diagnosis, represented by 2-digit area code (""Bundesland"")" 2-digit area code
Tumor diagnosis, ICD-10 code ICD-10 diagnostic code of tumor ICD-10, 4-digit code
Tumor diagnosis, ICD-10 version ICD-10 version used to encode tumor diagnosis ICD-10 version
Topography of tumor, ICD-O-3 code Tumor site represented by ICD-O-3 topography code ICD-O-3 (topography section) 4-digit code
Morphology of tumor, ICD-O-3 code Morphology and behavior of tumor represented by 5-digit ICD-O-3 code. The fifth digit indicates tumor behavior (/0 benign; /1 uncertain; /2 carcinoma in situ; /3 malignant). ICD-O-3 (morphology section), 5-digit code
Number of lymph nodes examined Number of lymph nodes that were examined for the presence of cancer cells (n) = number of lymph nodes
Number of lymph nodes affected Number of lymph nodes that contain cancer cells (n) = number of lymph nodes
cTNM: T Describes the size of the primary tumor. Staging according to tumor-specific TNM. T stage, tumor-specific
cTNM: N Describes the degree of spread to regional lymph nodes. Staging according to tumor-specific TNM. N stage, tumor-specific
cTNM: UICC Stage UICC Stage according to TNM. Describes the anatomical extent of disease. UICC stage, tumor-specific
pTNM: T Describes the size of the primary tumor. Staging according to tumor-specific TNM. T stage, tumor-specific
pTNM: N Describes the degree of spread to regional lymph nodes. Staging according to tumor-specific TNM. N stage, tumor-specific
pTNM: UICC stage UICC Stage according to TNM. Describes the anatomical extent of disease. UICC stage, tumor-specific
Other classification system: name Name and/or type of other classification(s) used e.g. Ann Arbor staging, WHO Classification of CNS Tumors, AJCC
Other classification system: stage Stage assigned based on other classification system Stage
Survival time Time interval between incidence date and death (n) = number of days
Tumor size Maximum diameter of invasive carcinoma (in mm) (n) = tumor size in mm
DCIS size Maximum diameter of ductal carcinoma in situ (in mm) (n) = DCIS size in mm
PSA level PSA level (ng/mL) (n) = level in ng/mL
PSA level date Date of PSA blood test Date YYYY-MM-DD
Gleason: primary grade Primary Gleason grade 1, 2, 3, 4 or 5
Gleason: secondary grade Secondary Gleason grade 1, 2, 3, 4 or 5
Gleason score Gleason score 2, 3, 4, 5, 6, 7, 7a, 7b, 8, 9 or 10
Tumor thickness Thickness of tumor (mm) (n) = thickness in mm
LDH level LDH level (units per liter) (n) = level in U/L
Surgery date Surgery date represented in ISO 8601 format YYYY-MM-DD. Year and month of surgery are collected from registries, day of surgery is assigned an arbitrary value. Date YYYY-MM-DD
Surgery type OPS code of surgery OPS code
OPS version OPS version used to encode surgery type OPS version number
Time to surgery Number of days between diagnosis and surgery (n) = number of days
Radiotherapy start date Radiotherapy start date Date YYYY-MM-DD
Percutaneous radiotherapy - Stereotactic Indicates if percutaneous radiotherapy (external beam radiotherapy) was applied using stereotactic techniques. ST = stereotactic
Percutaneous radiotherapy - Respiratory-gated Indicates if percutaneous radiotherapy (external beam radiotherapy) was respiratory-gated. 4D = respiratory-gated
Radiotherapy duration Number of days between diagnosis and surgery (n) = number of days
Time to radiotherapy Time interval between incidence date and radiotherapy start date (days) (n) = number of days
Systemic therapy drug Medication(s) used for systemic therapy. Multiple medications require separate entries. Name or: ATC code + ATC version
Systemic therapy protocol type Systemic therapy protocol name or code. "Name or: protocol code
Systemic therapy protocol Systemic therapy protocol code. Suggested guidance: https://plattform65c.atlassian.net/wiki/spaces/UMK/pages/15532519/Protokolle
Systemic therapy protocol Systemic therapy protocol name (name) = protocol name
Systemic therapy protocol Systemic therapy protocol version (version) = protocol version
Systemic therapy start date Systemic therapy start date Date YYYY-MM-DD
Systemic therapy duration Systemic therapy duration (days) (n) = number of days
Time to systemic therapy Time interval between incidence date and systemic therapy start date (days) (n) = number of days
Follow-up date Date of most recent follow-up evaluation of tumor status Date YYYY-MM-DD
TNM: T Describes the size of the primary tumor. Staging according to tumor-specific TNM. T stage, tumor-specific
TNM: N Describes the degree of spread to regional lymph nodes. Staging according to tumor-specific TNM. N stage, tumor-specific
TNM: UICC stage UICC Stage at follow-up according to TNM. Describes the anatomical extent of disease. UICC stage, tumor-specific
Other classification system: name Name and/or type of other classification(s) used e.g. Ann Arbor staging, WHO Classification of CNS Tumors, AJCC
Other classification system: stage Stage assigned based on other classification system Stage
Retrieved from "https://wiki.beaconcancer.org/index.php?title=Data_Dictionary:_ZfkD_Cancer_Registry_(Germany)&oldid=19680"
Powered by MediaWiki
Powered by Semantic MediaWiki